# Feature 011 K19 primary review

K17/K18 accepted and recorded; Issues #460–#466 closed. K19 T070–T073 technically PASS, pending Product Owner acceptance. T074–T092 untouched; stop before K20.

16 valid initial RED assertions; two additional offline-receipt and lineage-label defects reproduced with valid RED. Current focused suite 21/21; admin 41/41, i18n 13/13, shared patient/clinic copy 29/29, exposure 27/27. Both real runtimes passed shifaa-local-postgres: 59 checks; shifaa-local-supabase: 59 checks with exact temporary cleanup. Build, typechecks, architecture, secrets and current 133-pin P1–P5 parity PASS.

Real generated client, native Supabase AAL2 and non-owner SQL composition. Existing session login handoff uses a synthetic transport fixture carrying real native tokens; no new authentication or permissions. Degraded transport states are labeled fixtures, while actual API default-off/kill-switch negatives also passed. Neutral admission/read fixtures are private audited test setup, never client provisioning or clinical truth.

Local Chrome engineering evidence, 200% text and 400% reflow-equivalent layout; no manual screen-reader certification, reference-environment closure, production/clinical/MVP/final-design claim. All retained gates stay unchanged. No delegation, SQL/schema/contract changes, commit, push, PR or main modification.

Full evidence, source hashes, files, failure/retry notes and git status: checkpoint-review.json.
